cancer drug

Bristol-Myers: Liver cancer drug failed in study

Newsvine - business  Thu, 12/22/2011 - 16:13

A key experimental liver cancer drug that Bristol-Myers Squibb Co. has been testing did not meet the main goal of a late-stage study.


 

Erlotinib effective and with fewer side-effects after first-line...

http://www.eurekalert.org/rss/business.xml  Fri, 02/25/2011 - 23:00

(European Society for Medical Oncology) The targeted cancer drug erlotinib has comparable efficacy to chemotherapy, and is better tolerated, in hard-to-treat cases where a patient's cancer has progressed quickly after treatment with first-line therapy, the results of a new phase III trial show.


 

Investigational ovarian cancer drug shows promise against platin...

http://www.eurekalert.org/rss/business.xml  Fri, 10/08/2010 - 22:00

(European Society for Medical Oncology) A drug being developed as a treatment for ovarian cancer has shown single agent activity with durable disease control in some patients in a Phase-II clinical trial, an international research group has reported


 

Drugmaker Eli Lilly reports 4Q profit, sales jump

Newsvine - business  Thu, 01/28/2010 - 05:51

Pharmaceutical company Eli Lilly and Co. says it turned a fourth-quarter profit after recording a loss in 2008 following the buyout of cancer drug maker ImClone Systems Inc.


 

Geron cancer drug meets midstage study goals

Newsvine - business  Tue, 12/08/2009 - 17:06

Biotechnology company Geron Corp. said Tuesday its developing cancer treatment GRNVAC1 met safety and tolerability goals in a midstage study.


 

Poniard cancer drug misses goal in lung cancer

Newsvine - business  Mon, 11/16/2009 - 08:07

Poniard Pharmaceuticals Inc. said Monday its cancer drug candidate picoplatin did not help lung cancer patients live longer, sending its shares plunging in early trading.


 

FDA panel wants more data on Genzyme cancer drug

Newsvine - business  Tue, 09/01/2009 - 09:59

A panel of cancer experts has issued a negative review of a leukemia drug from Genzyme, saying more data is needed to establish its safety and efficacy for older patients.


 

Patent ruling on Lilly drug stirs some surprise

Newsvine - business  Tue, 08/18/2009 - 13:44

A federal court ruling that invalidated a patent protecting Eli Lilly and Co.'s cancer drug Gemzar surprised at least one analyst covering the company but stirred little reaction from investors in trading Tuesday.


 

Amgen says Vectibix met goal in colon cancer study

Newsvine - business  Thu, 08/06/2009 - 15:36

Amgen Inc. said Thursday its cancer drug Vectibix succeeded in a clinical trial, as the study showed the drug was more effective than chemotherapy alone as a primary treatment for colon cancer.


 

FDA panel votes against J&J cancer drug benefits

Newsvine - business  Wed, 07/15/2009 - 10:28

A Food and Drug Administration panel has ruled that the benefits of an experimental drug from Johnson & Johnson do not outweigh its risks, according to an agency spokeswoman.